Skip to main content
OpenTrials

Clinical trial condition

Blood Platelet Disorders

Explore clinical trials studying Blood Platelet Disorders. Study availability and eligibility vary by location and protocol.

957 public trials 209 recruiting studies
Refine in advanced search Browse all conditions

Blood Platelet Disorders trial results

Completed

Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP

NCT05613296

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • AON SS. ANTONIO E BIAGIO E C. ARRIGO - SS emostasi e trombosi Alessandria, Italy
  • SOD Clinica Ematologica AOU Ospedali Riuniti Umberto I GM Lancisi G Salesi Ancona, Italy
  • UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Bari, Italy
  • Istituto di Ematologia "Lorenzo e A. Seragnoli" Policlinico S. Orsola Bologna, Italy
View all 21 locations
View Trial Details
Completed

Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

NCT02298075

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • S.O.C. di Medicina Interna B - Ospedale - Cardinal Massaia di Asti Asti, Italy
  • Istituto di Ematologia "Lorenzo e A. Seragnoli" Bologna, Italy
  • Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi Catania, Italy
  • Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano Florence, Italy
View all 13 locations
View Trial Details
Completed

A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts

NCT05583838

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • The Second Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China
  • the Second Hospital of HeBei Medical University Shijiazhuang, Hebei, China
  • North China University of Science and Technology Affiliated Hospital Tangshan, Heibei, China
  • The Second Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China
View all 17 locations
View Trial Details
Completed

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

NCT00588991

Conditions
Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, +55 more
Locations
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details
Completed

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

NCT04188379

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigator Site 0010038 Tucson, Arizona, United States
  • Investigator Site 0010045 Washington D.C., District of Columbia, United States
  • Investigator Site 0010034 Jacksonville, Florida, United States
  • Investigator site 0010037 Ocala, Florida, United States
View all 121 locations
View Trial Details

Related conditions